Why This Connecticut Biotech Could be a $1M Opportunity for Investors Post author:Sam Post published:January 23, 2018 Post category:BioPharma Could Cara be the answer for investors itching to make $1 million? Source: BioSpace You Might Also Like Hemovent Files Two Additional Patent Applications For Its Portable ECMO Device For Both Circulatory And Respiratory Support March 21, 2017 University of Tubingen Release: Neurosciences: A Stress Test For Men And Women February 5, 2017 PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update May 11, 2017
Hemovent Files Two Additional Patent Applications For Its Portable ECMO Device For Both Circulatory And Respiratory Support March 21, 2017
